Celularity Inc (CELU)

03:35 AM

Celularity (NASDAQ:CELU) Trading 7.4% Higher – Here’s Why - Defense World

03:35 AM

May 20, 2025

Celularity extends debt maturity, issues stock to YA II PN By Investing.com - Investing.com India

May 20, 2025

May 20, 2025

Celularity extends debt maturity, issues stock to YA II PN - Investing.com

May 20, 2025

May 20, 2025

Celularity Extends Note Maturity with YA II PN - TipRanks

May 20, 2025

May 14, 2025

Celularity Inc. Advances Placental-Derived Therapies - TipRanks

May 14, 2025

May 09, 2025

Celularity (CELU) Reports Significant Revenue Growth in FY24 | C - GuruFocus

May 09, 2025

May 09, 2025

Celularity Announces Full Year 2024 Operating and Financial Results - The Manila Times

May 09, 2025

May 09, 2025

Celularity Inc. Reports Strong Financial Growth and Increased Revenue for Year Ended December 31, 2024 - Nasdaq

May 09, 2025

May 08, 2025

Celularity Inc SEC 10-K Report - TradingView

May 08, 2025

May 02, 2025

Nvidia (NVDA) Targets Trillion Dollar Opportunity as Trump Ponders Lifting AI Chip Curbs - The Globe and Mail

May 02, 2025

Apr 29, 2025

The end of La Niña: Lessons about Plains wheat drought & why spring weather is bearish for most grain markets - The Globe and Mail

Apr 29, 2025

Apr 28, 2025

Earnings To Watch: Caesars Entertainment (CZR) Reports Q1 Results Tomorrow - The Globe and Mail

Apr 28, 2025

Apr 26, 2025

Celularity (CELU) Resolves Nasdaq Fee Issue to Avoid Delisting | - GuruFocus

Apr 26, 2025

Apr 26, 2025

Celularity (NASDAQ:CELU) Stock Price Down 4.7% – Time to Sell? - Defense World

Apr 26, 2025

Apr 26, 2025

Celularity pays $70,000 fee to Nasdaq following receipt of notice - MSN

Apr 26, 2025

Apr 26, 2025

Celularity Receives Nasdaq Notice Regarding Non-Payment of Nasdaq Fees - The Manila Times

Apr 26, 2025

Apr 25, 2025

Celularity Inc. Faces Potential Delisting from Nasdaq Due to Fee and Filing Delinquencies - Nasdaq

Apr 25, 2025

Apr 25, 2025

Celularity Given Until May 1 to Address Dual Nasdaq Compliance Issues or Face Delisting - Stock Titan

Apr 25, 2025

Apr 24, 2025

Celularity faces Nasdaq delisting over late filing By Investing.com - Investing.com India

Apr 24, 2025

Apr 23, 2025

Celularity faces Nasdaq delisting over late filing - Investing.com

Apr 23, 2025

Apr 14, 2025

Celularity Welcomes CMS Action on Medicare Local Coverage Determination for Skin Substitutes Products - The Manila Times

Apr 14, 2025

Apr 14, 2025

CMS Extends Medicare Coverage for Wound Care Products: Major Win for Skin Substitute Market - Stock Titan

Apr 14, 2025

Apr 07, 2025

Revolutionary NK Cell Therapy Shows Promise in Cancer Treatment: New Research Reveals - Stock Titan

Apr 07, 2025

Apr 04, 2025

Celularity Announces Publication of “Senescence, NK cells, and cancer: navigating the crossroads of aging and disease” in the April 4, 2025, Issue of Frontiers in Immunology - The Globe and Mail

Apr 04, 2025

Mar 31, 2025

Celularity Delays Yearly Report Filing Amid Financial Challenges - TipRanks

Mar 31, 2025

Mar 22, 2025

Celularity extends debt maturity, issues stock to investor By Investing.com - Investing.com Australia

Mar 22, 2025

Mar 21, 2025

Celularity enters into standby equity purchase agreement with Ya Ii Pn -March 21, 2025 at 04:39 pm EDT - MarketScreener

Mar 21, 2025

Mar 21, 2025

Celularity enters into standby equity purchase agreement with Ya Ii Pn - TradingView

Mar 21, 2025

Mar 17, 2025

Robust Growth in Regenerative Placental Cell Therapy Market - openPR.com

Mar 17, 2025

Feb 28, 2025

Celularity receives FDA TRG recommendation letters for Natalin, Acelagraft - MSN

Feb 28, 2025

Feb 28, 2025

CELU Stock Touches 52-Week Low at $1.29 Amid Market Challenges - Investing.com Australia

Feb 28, 2025

Feb 27, 2025

CELU Stock Touches 52-Week Low at $1.29 Amid Market Challenges By Investing.com - Investing.com South Africa

Feb 27, 2025

Feb 26, 2025

Celularity Enters Strategic Collaboration Agreement with BlueSphere Bio to Support Cell Therapy Manufacturing - Defense World

Feb 26, 2025

Feb 25, 2025

Celularity Receives FDA Tissue Reference Group Recommendation Letters for its Natalin and Acelagraft™ Wound Care Products - The Manila Times

Feb 25, 2025

Feb 25, 2025

Celularity Secures Crucial FDA Pathway for Wound Care ProductsCan They Capture Share of $810M Market? - StockTitan

Feb 25, 2025

Feb 24, 2025

Celularity inks manufacturing deal with BlueSphere Bio By Investing.com - Investing.com Australia

Feb 24, 2025

Feb 24, 2025

Celularity inks manufacturing deal with BlueSphere Bio - Investing.com

Feb 24, 2025

Feb 24, 2025

Celularity Enters Strategic Collaboration Agreement with Clinical Stage Cell Therapy Company - The Manila Times

Feb 24, 2025

Feb 24, 2025

Can This New Cell Therapy Manufacturing Deal Transform Celularity's Revenue Potential? - StockTitan

Feb 24, 2025

Feb 21, 2025

Celularity Inc.'s (NASDAQ:CELU) Business And Shares Still Trailing The Industry - Simply Wall St

Feb 21, 2025

Feb 20, 2025

Celularity Inc. Extends Loan Agreements with Resorts World Inc and C.V. Starr & Co. - Defense World

Feb 20, 2025

Feb 13, 2025

SEC Form FWP filed by Celularity Inc. - Quantisnow

Feb 13, 2025

Feb 10, 2025

Celularity Inc (CELU) Stock: Analyzing the Market Value - The News Heater

Feb 10, 2025

Feb 06, 2025

Celularity Inc (CELU) Stock: A Year of Stock Market Dynamics - The InvestChronicle

Feb 06, 2025

Feb 06, 2025

Placental Stem Cell Therapy Solution Market Size And Booming - openPR

Feb 06, 2025

Feb 01, 2025

Celularity files to sell 6.52M shares of Class A common stock, warrants - MSN

Feb 01, 2025